HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE

Abstract

Aspects of heart rate-lowering therapy in patients with chronic heart failure using If-channel blocker ivabradine are discussed. The evidence-based data on ivabradine use reveal its advantages, disadvantages and place in the treatment of cardiac patients.

Keywords

• chronic heart failure
• heart rate-lowering therapy
• ivabradine